Celldex Therapeutics, Inc. Deferred Tax Assets, Tax Deferred Expense, Other
Celldex Therapeutics, Inc. (CLDX) had Deferred Tax Assets, Tax Deferred Expense, Other of $1.62 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $1.62M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $429.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $398.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $373.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other | Deferred Tax Assets, Tax Deferred Expense, Other as first filed |
|---|---|---|
| 2025-12-31 | $1.62M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $429.00K 10-K · filed 2026-02-25 | |
| 2023-12-31 | $398.00K 10-K · filed 2025-02-27 | |
| 2022-12-31 | $373.00K 10-K · filed 2024-02-26 | |
| 2021-12-31 | $370.00K 10-K · filed 2023-02-28 | |
| 2020-12-31 | $325.00K 10-K · filed 2022-02-28 | |
| 2019-12-31 | $328.00K 10-K · filed 2021-03-29 | |
| 2018-12-31 | $316.00K 10-K · filed 2020-03-26 | $183.00K 10-K · filed 2019-03-07 |
| 2017-12-31 | $316.00K 10-K · filed 2019-03-07 | |
| 2016-12-31 | $894.00K 10-K · filed 2018-03-07 | |
| 2015-12-31 | $219.00K 10-K · filed 2017-03-14 | |
| 2014-12-31 | $202.00K 10-K/A · filed 2016-02-25 | |
| 2013-12-31 | $176.00K 10-K · filed 2015-02-24 | $623.00K 10-K · filed 2014-03-03 |
| 2012-12-31 | $241.00K 10-K · filed 2014-03-03 | |
| 2011-12-31 | $197.00K 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |